# FDA 483 - Octapharma Plasma, Inc. - May 14, 2026

Source: https://www.keypedia.com/records/483/octapharma-plasma-inc/bb085cad-60f7-41ca-bc9f-d3e4a5570e6e

> FDA 483 for Octapharma Plasma, Inc. on May 14, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2026-05-14
- Product Type: biologics
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: An FDA inspection of Octapharma Plasma Inc in Mesa, AZ, a source plasma donation center, identified one observation. The primary concern was that equipment used for storing and distributing blood and blood components was not properly observed, standardized, or calibrated. Specifically, a printer used for plasma unit distribution labels lacked an installation qualification to verify label accuracy.

## Related Documents

- [483 - Unknown Date](https://www.keypedia.com/records/483/octapharma-plasma-inc/3b244f9f-8d97-43d1-a04a-027e770f4f76)

## Related Officers

- [Garrad R. Poole](https://www.keypedia.com/people/garrad-r-poole/7fc97953-367e-459b-905d-25efe6ec39d2)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/1250700e-204f-4fe1-91f2-0500280f5abc

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6